Mark J. Tarr's Insider Trades & SAST Disclosures
Mark J. Tarr's most recent trade in Encompass Health Corp was a trade of 33,086 Non-qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark J. Tarr.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 33,086 | 33,086 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.14 per share. | 28 Feb 2025 | 2,187 | 527,070 (0%) | 0% | 100.1 | 219,006 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.63 per share. | 24 Feb 2025 | 2,896 | 529,257 (0%) | 0% | 100.6 | 291,424 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 97.53 per share. | 24 Feb 2025 | 2,488 | 532,153 (0%) | 0% | 97.5 | 242,655 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 12,152 | 534,641 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.35 per share. | 01 Jan 2025 | 31,609 | 522,489 (0%) | 0% | 92.3 | 2,919,091 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 83.27 per share. | 30 Apr 2024 | 44,976 | 554,098 (0%) | 0% | 83.3 | 3,745,152 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 25,516 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.06 per share. | 30 Apr 2024 | 25,516 | 599,074 (0%) | 0% | 29.1 | 741,495 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.83 per share. | 30 Apr 2024 | 19,460 | 573,558 (0%) | 0% | 35.8 | 697,252 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 19,460 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Encompass Health Corp | J. Tarr Mark | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 74,711 | 539,309 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Encompass Health Corp | J. Mark Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 14,789 | 554,098 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Encompass Health Corp | Mark Tarr J. | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 2,895 | 464,598 (0%) | 0% | 75.3 | 217,849 | Encompass Health Common Stock |
| Encompass Health Corp | Tarr Mark J. | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 2,487 | 469,749 (0%) | 0% | 75.3 | 187,147 | Encompass Health Common Stock |
| Encompass Health Corp | J. Tarr Mark | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.25 per share. | 23 Feb 2024 | 2,256 | 467,493 (0%) | 0% | 75.3 | 169,764 | Encompass Health Common Stock |
| Encompass Health Corp | J. Mark Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.72 per share. | 02 Jan 2024 | 25,159 | 472,236 (0%) | 0% | 66.7 | 1,678,608 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2023 | 25,330 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 71.06 per share. | 16 Aug 2023 | 25,330 | 497,405 (0%) | 0% | 71.1 | 1,799,950 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.55 per share. | 16 Aug 2023 | 25,330 | 522,735 (0%) | 0% | 26.6 | 672,512 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 49,498 | 49,498 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 2,895 | 497,395 (0%) | 0% | 60.2 | 174,337 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.22 per share. | 24 Feb 2023 | 2,256 | 500,290 (0%) | 0% | 60.2 | 135,856 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 61,503 | 485,722 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 16,824 | 502,546 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.86 per share. | 21 Feb 2023 | 2,100 | 424,219 (0%) | 0% | 62.9 | 132,006 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.81 per share. | 03 Jan 2023 | 14,576 | 426,319 (0%) | 0% | 59.8 | 871,791 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 53.25 per share. | 17 Aug 2022 | 20,449 | 440,895 (0%) | 0% | 53.2 | 1,088,909 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 20,449 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.07 per share. | 17 Aug 2022 | 20,449 | 461,344 (0%) | 0% | 20.1 | 410,411 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 61,039 | 61,039 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 31,730 | 428,557 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 16,258 | 396,827 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.52 per share. | 24 Feb 2022 | 1,873 | 380,569 (0%) | 0% | 65.5 | 122,719 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.91 per share. | 22 Feb 2022 | 3,782 | 382,442 (0%) | 0% | 65.9 | 249,272 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.26 per share. | 03 Jan 2022 | 11,327 | 386,224 (0%) | 0% | 65.3 | 739,200 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 53,410 | 53,410 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 30,468 | 384,882 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 12,669 | 397,551 (0%) | 0% | 0 | Encompass Health Common Stock | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.23 per share. | 23 Feb 2021 | 1,975 | 354,414 (0%) | 0% | 80.2 | 158,454 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 2,039 | 356,389 (0%) | 0% | 80.5 | 164,160 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. | 20 Feb 2021 | 1,743 | 358,428 (0%) | 0% | 80.5 | 140,329 | Encompass Health Common Stock |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.69 per share. | 04 Jan 2021 | 22,894 | 360,171 (0%) | 0% | 82.7 | 1,893,105 | Encompass Health Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges